Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina and a leading
cause of visual impairment and childhood blindness worldwide. The disease is …

At preterm birth, the retina is incompletely vascularized. Retinopathy of prematurity (ROP) is
initiated by the postnatal suppression of physiological retinal vascular development that …

There is a gap in understanding the effect of the essential ω-3 and ω-6 long-chain
polyunsaturated fatty acids (LCPUFA) on Phase I retinopathy of prematurity (ROP), which …

Retinopathy of prematurity is defined as retinal abnormalities that occur during development
as a consequence of disturbed oxygen conditions and nutrient supply after preterm birth …

Retinopathy of prematurity (ROP), a vasoproliferative vitreoretinal disorder, is the leading
cause of childhood blindness worldwide. Although angiogenic pathways have been the …

Background Cytokines and growth factors (GF) have been implicated in the development of
retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD). We hypothesize …

Purpose To evaluate complete blood count (CBC) parameters in the first week of life as
predictive biomarkers for the development of retinopathy of prematurity (ROP). Methods …

Aim Retinopathy of prematurity is a significant global cause of childhood blindness. This
study aims to identify serum biomarkers that are associated with the development of ROP …

Aim The aim of this review was to compile existing evidence on the role of platelets in the
development of severe retinopathy of prematurity (ROP), highlight the strengths and …

Introduction Ibuprofen is one of the most common non-steroidal anti-inflammatory drugs
used to close patent ductus arteriosus (PDA) in preterm infants. PDA is associated with …